UPAR and cathepsin B-mediated compartmentalization of JNK regulates the migration of glioma-initiating cells

Stem Cell Research

Volumn 12, Issue 3, 2014, Pages 716-729

  Alapati, Kiranmai ^a   Kesanakurti, Divya ^a   Rao, Jasti S ^a   Dasari, Venkata Ramesh ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 1; P21 ACTIVATED KINASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; RAS PROTEIN; STRESS ACTIVATED PROTEIN KINASE; UROKINASE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4;

ARTICLE; CELL ADHESION; CELL COMPARTMENTALIZATION; CELL MIGRATION; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; CYTOPLASM; CYTOSOL; FOCAL ADHESION; GLIOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; RADIATION; SIGNAL TRANSDUCTION; ANIMAL; CELL MOTION; CELL NUCLEUS; ENZYMOLOGY; FEMALE; GENETICS; GLIOMA; MALE; METABOLISM; MOUSE; PATHOPHYSIOLOGY; PROTEIN TRANSPORT;

ANIMALS; CATHEPSIN B; CELL MOVEMENT; CELL NUCLEUS; CYTOPLASM; CYTOSOL; FEMALE; GLIOMA; HUMANS; MALE; MAP KINASE KINASE 4; MAP KINASE SIGNALING SYSTEM; MICE; PROTEIN TRANSPORT; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR;

EID: 84897413625     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2014.02.008     Document Type: Article

References (60)

1. Ahmed N., Oliva K., Wang Y., Quinn M., Rice G. Downregulation of urokinase plasminogen activator receptor expression inhibits Erk signalling with concomitant suppression of invasiveness due to loss of uPAR-beta1 integrin complex in colon cancer cells. Br. J. Cancer 2003, 89:374-384.
2. Alapati K., Gopinath S., Malla R.R., Dasari V.R., Rao J.S. uPAR and cathepsin B knockdown inhibits radiation-induced PKC integrated integrin signaling to the cytoskeleton of glioma-initiating cells. Int. J. Oncol. 2012, 41:599-610.
3. Amagasaki K., Kaneto H., Heldin C.H., Lennartsson J. c-Jun N-terminal kinase is necessary for platelet-derived growth factor-mediated chemotaxis in primary fibroblasts. J. Biol. Chem. 2006, 281:22173-22179.
4. Besch R., Berking C., Kammerbauer C., Degitz K. Inhibition of urokinase-type plasminogen activator receptor induces apoptosis in melanoma cells by activation of p53. Cell Death Differ. 2007, 14:818-829.
5. Bjorkblom B., Ostman N., Hongisto V., Komarovski V., Filen J.J., Nyman T.A., Kallunki T., Courtney M.J., Coffey E.T. Constitutively active cytoplasmic c-Jun N-terminal kinase 1 is a dominant regulator of dendritic architecture: role of microtubule-associated protein 2 as an effector. J. Neurosci. 2005, 25:6350-6361.
6. Bjorkblom B., Vainio J.C., Hongisto V., Herdegen T., Courtney M.J., Coffey E.T. All JNKs can kill, but nuclear localization is critical for neuronal death. J. Biol. Chem. 2008, 283:19704-19713.
7. Bogoyevitch M.A., Kobe B. Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases. Microbiol. Mol. Biol. Rev. 2006, 70:1061-1095.
8. Chen H., Zhu G., Li Y., Padia R.N., Dong Z., Pan Z.K., Liu K., Huang S. Extracellular signal-regulated kinase signaling pathway regulates breast cancer cell migration by maintaining slug expression. Cancer Res. 2009, 69:9228-9235.
9. Coffey E.T., Hongisto V., Dickens M., Davis R.J., Courtney M.J. Dual roles for c-Jun N-terminal kinase in developmental and stress responses in cerebellar granule neurons. J. Neurosci. 2000, 20:7602-7613.
10. Cuevas B.D., Abell A.N., Johnson G.L. Role of mitogen-activated protein kinase kinase kinases in signal integration. Oncogene 2007, 26:3159-3171.
11. Dhanasekaran D.N., Reddy E.P. JNK signaling in apoptosis. Oncogene 2008, 27:6245-6251.
12. Dhillon A.S., Hagan S., Rath O., Kolch W. MAP kinase signalling pathways in cancer. Oncogene 2007, 26:3279-3290.
13. Dunn K.L., Espino P.S., Drobic B., He S., Davie J.R. The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling. Biochem. Cell Biol. 2005, 83:1-14.
14. Edwards D.R., Cancer Murphy G. Proteases-invasion and more. Nature 1998, 394:527-528.
15. Friedl P., Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat. Rev. Cancer 2003, 3:362-374.
16. Gallagher E.D., Xu S., Moomaw C., Slaughter C.A., Cobb M.H. Binding of JNK/SAPK to MEKK1 is regulated by phosphorylation. J. Biol. Chem. 2002, 277:45785-45792.
17. Gilbert C.A., Ross A.H. Cancer stem cells: cell culture, markers, and targets for new therapies. J. Cell. Biochem. 2009, 108:1031-1038.
18. Gossage L., Eisen T. Targeting multiple kinase pathways: a change in paradigm. Clin. Cancer Res. 2010, 16:1973-1978.
19. Hjelmeland A.B., Wu Q., Heddleston J.M., Choudhary G.S., MacSwords J., Lathia J.D., McLendon R., Lindner D., Sloan A., Rich J.N. Acidic stress promotes a glioma stem cell phenotype. Cell Death Differ. 2011, 18(5):829-840. (May).
20. Huang C., Jacobson K., Schaller M.D. A role for JNK-paxillin signaling in cell migration. Cell Cycle 2004, 3:4-6.
21. Huang C., Jacobson K., Schaller M.D. MAP kinases and cell migration. J. Cell Sci. 2004, 117:4619-4628.
22. Huang C., Rajfur Z., Borchers C., Schaller M.D., Jacobson K. JNK phosphorylates paxillin and regulates cell migration. Nature 2003, 424:219-223.
23. Huang Z., Yan D.P., Ge B.X. JNK regulates cell migration through promotion of tyrosine phosphorylation of paxillin. Cell. Signal. 2008, 20:2002-2012.
24. Huttenlocher A., Horwitz A.R. Integrins in cell migration. Cold Spring Harb. Perspect. Biol. 2011, 3:a005074.
25. Inoue A., Takahashi H., Harada H., Kohno S., Ohue S., Kobayashi K., Yano H., Tanaka J., Ohnishi T. Cancer stem-like cells of glioblastoma characteristically express MMP-13 and display highly invasive activity. Int. J. Oncol. 2010, 37:1121-1131.
26. Johnson G.L., Nakamura K. The c-jun kinase/stress-activated pathway: regulation, function and role in human disease. Biochim. Biophys. Acta 2007, 1773:1341-1348.
27. Kanazawa S., Fujiwara T., Matsuzaki S., Shingaki K., Taniguchi M., Miyata S., Tohyama M., Sakai Y., Yano K., Hosokawa K., et al. bFGF regulates PI3-kinase-Rac1-JNK pathway and promotes fibroblast migration in wound healing. PLoS One 2010, 5:e12228.
28. Kang K.B., Zhu C., Wong Y.L., Gao Q., Ty A., Wong M.C. Gefitinib radiosensitizes stem-like glioma cells: inhibition of epidermal growth factor receptor-Akt-DNA-PK signaling, accompanied by inhibition of DNA double-strand break repair. Int. J. Radiat. Oncol. Biol. Phys. 2012, 83:e43-e52.
29. Kil W.J., Tofilon P.J., Camphausen K. Post-radiation increase in VEGF enhances glioma cell motility in vitro. Radiat. Oncol. 2012, 7:25-27.
30. Lakka S.S., Gondi C.S., Yanamandra N., Olivero W.C., Dinh D.H., Gujrati M., Rao J.S. Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis. Oncogene 2004, 23:4681-4689.
31. Lathia J.D., Hitomi M., Gallagher J., Gadani S.P., Adkins J., Vasanji A., Liu L., Eyler C.E., Heddleston J.M., Wu Q., et al. Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions. Cell Death Dis. 2011, 2:e200.
32. Lawrence M.C., Jivan A., Shao C., Duan L., Goad D., Zaganjor E., Osborne J., McGlynn K., Stippec S., Earnest S., et al. The roles of MAPKs in disease. Cell Res. 2008, 18:436-442.
33. Levicar N., Nuttall R.K., Lah T.T. Proteases in brain tumour progression. Acta Neurochir. (Wien) 2003, 145:825-838.
34. Lind C.R., Gray C.W., Pearson A.G., Cameron R.E., O'Carroll S.J., Narayan P.J., Lim J., Dragunow M. The mitogen-activated/extracellular signal-regulated kinase kinase 1/2 inhibitor U0126 induces glial fibrillary acidic protein expression and reduces the proliferation and migration of C6 glioma cells. Neuroscience 2006, 141:1925-1933.
35. Malla R.R., Gopinath S., Alapati K., Gondi C.S., Gujrati M., Dinh D.H., Mohanam S., Rao J.S. Downregulation of uPAR and cathepsin B induces apoptosis via regulation of Bcl-2 and Bax and inhibition of the PI3K/Akt pathway in gliomas. PLoS One 2010, 5:e13731. (PMCID: PMC2966405).
36. Malla R.R., Gopinath S., Alapati K., Gorantla B., Gondi C.S., Rao J.S. uPAR and cathepsin B inhibition enhanced radiation-induced apoptosis in glioma initiating cells. Neuro Oncol. 2012, 14:745-760.
37. Malla R.R., Gopinath S., Gondi C.S., Alapati K., Dinh D.H., Tsung A.J., Rao J.S. uPAR and cathepsin B downregulation induces apoptosis by targeting calcineurin A to BAD via Bcl-2 in glioma. J. Neuro Oncol. 2012, 107:69-80.
38. Matarrese P., Ascione B., Ciarlo L., Vona R., Leonetti C., Scarsella M., Mileo A.M., Catricala C., Paggi M.G., Malorni W. Cathepsin B inhibition interferes with metastatic potential of human melanoma: an in vitro and in vivo study. Mol. Cancer 2010, 9:207. 10.1186/1476-4598-9-207:207-209.
39. Mohamed M.M., Sloane B.F. Cysteine cathepsins: multifunctional enzymes in cancer. Nat. Rev. Cancer 2006, 6:764-775.
40. Nalla A.K., Gorantla B., Gondi C.S., Lakka S.S., Rao J.S. Targeting MMP-9, uPAR, and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cells. Cancer Gene Ther. 2010, 17:599-613.
41. Nguyen D.H., Catling A.D., Webb D.J., Sankovic M., Walker L.A., Somlyo A.V., Weber M.J., Gonias S.L. Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner. J. Cell Biol. 1999, 146:149-164.
42. Owens D.M., Keyse S.M. Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases. Oncogene 2007, 26:3203-3213.
43. Qi M., Elion E.A. MAP kinase pathways. J. Cell Sci. 2005, 118:3569-3572.
44. Rabbani S.A., Ateeq B., Arakelian A., Valentino M.L., Shaw D.E., Dauffenbach L.M., Kerfoot C.A., Mazar A.P. An anti-urokinase plasminogen activator receptor antibody (ATN-658) blocks prostate cancer invasion, migration, growth, and experimental skeletal metastasis in vitro and in vivo. Neoplasia 2010, 12:778-788.
45. Raman M., Chen W., Cobb M.H. Differential regulation and properties of MAPKs. Oncogene 2007, 26:3100-3112.
46. Rao J.S. Molecular mechanisms of glioma invasiveness: the role of proteases. Nat. Rev. Cancer 2003, 3:489-501.
47. Rosse C., Formstecher E., Boeckeler K., Zhao Y., Kremerskothen J., White M.D., Camonis J.H., Parker P.J. An aPKC-exocyst complex controls paxillin phosphorylation and migration through localised JNK1 activation. PLoS Biol. 2009, 7:e1000235.
48. Santarpia L., Lippman S.M., El-Naggar A.K. Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy. Expert Opin. Ther. Targets 2012, 16:103-119.
49. Sevenich L., Werner F., Gajda M., Schurigt U., Sieber C., Muller S., Follo M., Peters C., Reinheckel T. Transgenic expression of human cathepsin B promotes progression and metastasis of polyoma-middle-T-induced breast cancer in mice. Oncogene 2011, 30:54-64.
50. 2-terminal kinase signaling mediates collagen I-induced cell scattering and up-regulation of N-cadherin expression in mouse mammary epithelial cells. Mol. Biol. Cell 2006, 17:2963-2975.
51. Smith H.W., Marshall C.J. Regulation of cell signalling by uPAR. Nat. Rev. Mol. Cell Biol. 2010, 11:23-36.
52. Stappenbeck T.S., Gordon J.I. Extranuclear sequestration of phospho-Jun N-terminal kinase and distorted villi produced by activated Rac1 in the intestinal epithelium of chimeric mice. Development 2001, 128:2603-2614.
53. Stupp R., Mason W.P., van den Bent M.J., Weller M., Fisher B., Taphoorn M.J., Belanger K., Brandes A.A., Marosi C., Bogdahn U., et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 2005, 352:987-996.
54. Turjanski A.G., Vaque J.P., Gutkind J.S. MAP kinases and the control of nuclear events. Oncogene 2007, 26:3240-3253.
55. Veeravalli K.K., Chetty C., Ponnala S., Gondi C.S., Lakka S.S., Fassett D., Klopfenstein J.D., Dinh D.H., Gujrati M., Rao J.S. MMP-9, uPAR and cathepsin B silencing downregulate integrins in human glioma xenograft cells in vitro and in vivo in nude mice. PLoS One 2010, 5:e11583. (PMCID: PMC2904700).
56. Vicente-Manzanares M., Choi C.K., Horwitz A.R. Integrins in cell migration-the actin connection. J. Cell Sci. 2009, 122:199-206.
57. Victor B.C., Anbalagan A., Mohamed M.M., Sloane B.F., Cavallo-Medved D. Inhibition of cathepsin B activity attenuates extracellular matrix degradation and inflammatory breast cancer invasion. Breast Cancer Res. 2011, 13:R115.
58. 2-kinase activity promotes epithelial-mesenchymal transition, invasion, and survival of breast cancer cells by regulating extracellular signal-regulated kinase activation. Mol. Cancer Res. 2010, 8:266-277.
59. Wegiel B., Jiborn T., Abrahamson M., Helczynski L., Otterbein L., Persson J.L., Bjartell A. Cystatin C is downregulated in prostate cancer and modulates invasion of prostate cancer cells via MAPK/Erk and androgen receptor pathways. PLoS One 2009, 4:e7953.
60. Wu W.S., Wu J.R., Hu C.T. Signal cross talks for sustained MAPK activation and cell migration: the potential role of reactive oxygen species. Cancer Metastasis Rev. 2008, 27:303-314.